Pills, Power, and Policy

Pills, Power, and Policy

The Struggle for Drug Reform in Cold War America and Its Consequences

By Dominique Tobbell
Paperback $34.95 eBook $34.95 Hardcover $75.00

$34.95

Publication Date: 7th December 2011

Since the 1950s, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with... Read More
0 in stock
Since the 1950s, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with... Read More
Description
Since the 1950s, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with the medical profession, staunchly and successfully opposed regulation.Pills, Power, and Policyoffers a lucid history of how the American drug industry and key sectors of the medical profession came to be allies against pharmaceutical reform. It details the political strategies they have used to influence public opinion, shape legislative reform, and define the regulatory environment of prescription drugs. Untangling the complex relationships between drug companies, physicians, and academic researchers, the book provides essential historical context for understanding how corporate interests came to dominate American health care policy after World War II.
Details
  • Price: $34.95
  • Pages: 310
  • Carton Quantity: 24
  • Publisher: University of California Press
  • Imprint: University of California Press
  • Series: California/Milbank Books on Health and the Public
  • Publication Date: 7th December 2011
  • Trim Size: 6 x 9 in
  • Illustration Note: 1 table
  • ISBN: 9780520271142
  • Format: Paperback
  • BISACs:
    MEDICAL / Health Care Delivery
    MEDICAL / Health Policy
    MEDICAL / History
Reviews
“Tobbell contributes . . . fine historical attention to the development of large pharmaceutical companies . . . with a longer story of lobbying and politics.”
- Times Higher Education
“Based on extensive research, Pills, Power, and Policy is intelligently written, and its points are illustrated with highly readable examples.”
- Health Affairs
“[A] well-researched and skillfully argued volume.”
- Scott H. Podolsky, Harvard Medical School, Bulletin Of The History Of Medicine
“Pills, Power, and Policy is an important contribution to our understanding of the science and politics of the pharmaceutical industry.”
- Mical Raz, M.D., Ph.D. –– Yale University School of Medicine, Inquiry
Author Bio
Dominique A. Tobbell is Assistant Professor in the Program in the History of Medicine and the Graduate Program in the History of Science, Technology, and Medicine at the University of Minnesota, Twin Cities. She is also the oral historian for the University of Minnesota’s Academic Health Center History Project.
Table of Contents
Foreword
Acknowledgments

Introduction: Pharmaceutical Politics, Then and Now

Part I: Forging Pharmaceutical Relations
1. Knowledgeable Relations: The Building of a Pharmaceutical Research Network
2. Workforce Relations: The Invention of the Pharmaceutical Postdoctoral Fellowship
3. Professional Relations: Crafting the Public Image of the Health Care Team

Part II: Allied against Reform
4. Cold War Alliances: Kefauver’s Bid for Pharmaceutical Reform
5. Expert Alliances: The Creation of the Drug Research Board
6. Generic Alliances and the Backlash against Regulatory Reform

Epilogue

Notes
Bibliography
Index
Since the 1950s, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with the medical profession, staunchly and successfully opposed regulation.Pills, Power, and Policyoffers a lucid history of how the American drug industry and key sectors of the medical profession came to be allies against pharmaceutical reform. It details the political strategies they have used to influence public opinion, shape legislative reform, and define the regulatory environment of prescription drugs. Untangling the complex relationships between drug companies, physicians, and academic researchers, the book provides essential historical context for understanding how corporate interests came to dominate American health care policy after World War II.
  • Price: $34.95
  • Pages: 310
  • Carton Quantity: 24
  • Publisher: University of California Press
  • Imprint: University of California Press
  • Series: California/Milbank Books on Health and the Public
  • Publication Date: 7th December 2011
  • Trim Size: 6 x 9 in
  • Illustrations Note: 1 table
  • ISBN: 9780520271142
  • Format: Paperback
  • BISACs:
    MEDICAL / Health Care Delivery
    MEDICAL / Health Policy
    MEDICAL / History
“Tobbell contributes . . . fine historical attention to the development of large pharmaceutical companies . . . with a longer story of lobbying and politics.”
– Times Higher Education
“Based on extensive research, Pills, Power, and Policy is intelligently written, and its points are illustrated with highly readable examples.”
– Health Affairs
“[A] well-researched and skillfully argued volume.”
– Scott H. Podolsky, Harvard Medical School, Bulletin Of The History Of Medicine
“Pills, Power, and Policy is an important contribution to our understanding of the science and politics of the pharmaceutical industry.”
– Mical Raz, M.D., Ph.D. –– Yale University School of Medicine, Inquiry
Dominique A. Tobbell is Assistant Professor in the Program in the History of Medicine and the Graduate Program in the History of Science, Technology, and Medicine at the University of Minnesota, Twin Cities. She is also the oral historian for the University of Minnesota’s Academic Health Center History Project.
Foreword
Acknowledgments

Introduction: Pharmaceutical Politics, Then and Now

Part I: Forging Pharmaceutical Relations
1. Knowledgeable Relations: The Building of a Pharmaceutical Research Network
2. Workforce Relations: The Invention of the Pharmaceutical Postdoctoral Fellowship
3. Professional Relations: Crafting the Public Image of the Health Care Team

Part II: Allied against Reform
4. Cold War Alliances: Kefauver’s Bid for Pharmaceutical Reform
5. Expert Alliances: The Creation of the Drug Research Board
6. Generic Alliances and the Backlash against Regulatory Reform

Epilogue

Notes
Bibliography
Index